News articles about Centene Corporation (NYSE:CNC) have trended somewhat positive on Monday, Accern reports. Accern ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Centene Corporation earned a news sentiment score of 0.18 on Accern’s scale. Accern also assigned headlines about the company an impact score of 46.7258005718588 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
These are some of the headlines that may have impacted Accern Sentiment’s scoring:
- Origo Acquisition Corporation (NASDAQ:OACQ) Files An 8-K Regulation FD Disclosure (4-traders.com)
- Sacramento strikes deal with health insurer that may bring up to 5000 jobs – Sacramento Business Journal (bizjournals.com)
- Sacramento strikes deal with health insurer that may bring up to 5,000 jobs (finance.yahoo.com)
- Stocks rebounding after early losses, financials leading (finance.yahoo.com)
- Fact-Checking Democratic Claims About Repealing Obamacare’s Individual Mandate (finance.yahoo.com)
CNC has been the subject of several research reports. Cowen and Company reaffirmed a “buy” rating and set a $115.00 price target on shares of Centene Corporation in a research note on Tuesday, October 24th. Oppenheimer Holdings, Inc. increased their price objective on Centene Corporation from $105.00 to $111.00 and gave the company an “outperform” rating in a report on Wednesday, October 25th. Jefferies Group LLC increased their price objective on Centene Corporation from $98.00 to $112.00 and gave the company a “buy” rating in a report on Friday, October 13th. Zacks Investment Research raised Centene Corporation from a “hold” rating to a “buy” rating and set a $107.00 price objective for the company in a report on Friday, September 15th. Finally, Deutsche Bank AG reissued a “buy” rating and issued a $111.00 price objective (up previously from $95.00) on shares of Centene Corporation in a report on Thursday, September 14th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and seventeen have assigned a buy rating to the company’s stock. Centene Corporation currently has an average rating of “Buy” and an average target price of $99.11.
Centene Corporation (NYSE CNC) traded down $0.80 on Monday, hitting $95.14. The stock had a trading volume of 1,005,000 shares, compared to its average volume of 1,700,652. Centene Corporation has a 12 month low of $54.40 and a 12 month high of $98.71. The company has a quick ratio of 0.99, a current ratio of 0.99 and a debt-to-equity ratio of 0.71. The firm has a market capitalization of $16,420.00, a P/E ratio of 18.12, a P/E/G ratio of 1.45 and a beta of 0.67.
Centene Corporation (NYSE:CNC) last posted its earnings results on Tuesday, October 24th. The company reported $1.35 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.24 by $0.11. Centene Corporation had a return on equity of 14.79% and a net margin of 1.81%. The company had revenue of $11.90 billion during the quarter, compared to the consensus estimate of $11.75 billion. During the same quarter last year, the firm earned $1.12 earnings per share. The company’s revenue was up 9.7% on a year-over-year basis. sell-side analysts expect that Centene Corporation will post 4.98 EPS for the current year.
In other news, Director Robert K. Ditmore sold 4,167 shares of Centene Corporation stock in a transaction on Thursday, October 26th. The stock was sold at an average price of $90.42, for a total transaction of $376,780.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 3.00% of the stock is currently owned by company insiders.
Centene Corporation Company Profile
Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.
Receive News & Ratings for Centene Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene Corporation and related companies with MarketBeat.com's FREE daily email newsletter.